• info@reportsandmarkets.com
  • +44-020-3286-9338 (UK) | +1-214-736-7666 (US) | +1-740-994-0111 (US)
  • Sign In
  • Register

Pharma & Healthcare2018-2023 Global Gastrointestinal Drugs Consumption Market Report

  • RnM2475710
  • |
  • 29 August, 2018
  • |
  • Global
  • |
  • 159 pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Gastrointestinal Drugs market for 2018-2023.

Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
Over the next five years, LPI(LP Information) projects that Gastrointestinal Drugs will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal Drugs market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
Segmentation by application:
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
AstraZeneca
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria(Tillotts)
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Gastrointestinal Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Gastrointestinal Drugs market by identifying its various subsegments.
Focuses on the key global Gastrointestinal Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Gastrointestinal Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Gastrointestinal Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

2018-2023 Global Gastrointestinal Drugs Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gastrointestinal Drugs Consumption 2013-2023
2.1.2 Gastrointestinal Drugs Consumption CAGR by Region
2.2 Gastrointestinal Drugs Segment by Type
2.2.1 Prescription Gastrointestinal Drug
2.2.2 OTC Gastrointestinal Drug
2.3 Gastrointestinal Drugs Consumption by Type
2.3.1 Global Gastrointestinal Drugs Consumption Market Share by Type (2013-2018)
2.3.2 Global Gastrointestinal Drugs Revenue and Market Share by Type (2013-2018)
2.3.3 Global Gastrointestinal Drugs Sale Price by Type (2013-2018)
2.4 Gastrointestinal Drugs Segment by Application
2.4.1 Chronic Gastritis
2.4.2 Functional Dyspepsia
2.4.3 Peptic Ulcer
2.4.4 Acute Gastroenteritis
2.4.5 Other
2.5 Gastrointestinal Drugs Consumption by Application
2.5.1 Global Gastrointestinal Drugs Consumption Market Share by Application (2013-2018)
2.5.2 Global Gastrointestinal Drugs Value and Market Share by Application (2013-2018)
2.5.3 Global Gastrointestinal Drugs Sale Price by Application (2013-2018)

3 Global Gastrointestinal Drugs by Players
3.1 Global Gastrointestinal Drugs Sales Market Share by Players
3.1.1 Global Gastrointestinal Drugs Sales by Players (2016-2018)
3.1.2 Global Gastrointestinal Drugs Sales Market Share by Players (2016-2018)
3.2 Global Gastrointestinal Drugs Revenue Market Share by Players
3.2.1 Global Gastrointestinal Drugs Revenue by Players (2016-2018)
3.2.2 Global Gastrointestinal Drugs Revenue Market Share by Players (2016-2018)
3.3 Global Gastrointestinal Drugs Sale Price by Players
3.4 Global Gastrointestinal Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Gastrointestinal Drugs Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Gastrointestinal Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Gastrointestinal Drugs by Regions
4.1 Gastrointestinal Drugs by Regions
4.1.1 Global Gastrointestinal Drugs Consumption by Regions
4.1.2 Global Gastrointestinal Drugs Value by Regions
4.2 Americas Gastrointestinal Drugs Consumption Growth
4.3 APAC Gastrointestinal Drugs Consumption Growth
4.4 Europe Gastrointestinal Drugs Consumption Growth
4.5 Middle East & Africa Gastrointestinal Drugs Consumption Growth

5 Americas
5.1 Americas Gastrointestinal Drugs Consumption by Countries
5.1.1 Americas Gastrointestinal Drugs Consumption by Countries (2013-2018)
5.1.2 Americas Gastrointestinal Drugs Value by Countries (2013-2018)
5.2 Americas Gastrointestinal Drugs Consumption by Type
5.3 Americas Gastrointestinal Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Gastrointestinal Drugs Consumption by Countries
6.1.1 APAC Gastrointestinal Drugs Consumption by Countries (2013-2018)
6.1.2 APAC Gastrointestinal Drugs Value by Countries (2013-2018)
6.2 APAC Gastrointestinal Drugs Consumption by Type
6.3 APAC Gastrointestinal Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Gastrointestinal Drugs by Countries
7.1.1 Europe Gastrointestinal Drugs Consumption by Countries (2013-2018)
7.1.2 Europe Gastrointestinal Drugs Value by Countries (2013-2018)
7.2 Europe Gastrointestinal Drugs Consumption by Type
7.3 Europe Gastrointestinal Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Gastrointestinal Drugs by Countries
8.1.1 Middle East & Africa Gastrointestinal Drugs Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Gastrointestinal Drugs Value by Countries (2013-2018)
8.2 Middle East & Africa Gastrointestinal Drugs Consumption by Type
8.3 Middle East & Africa Gastrointestinal Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Gastrointestinal Drugs Distributors
10.3 Gastrointestinal Drugs Customer

11 Global Gastrointestinal Drugs Market Forecast
11.1 Global Gastrointestinal Drugs Consumption Forecast (2018-2023)
11.2 Global Gastrointestinal Drugs Forecast by Regions
11.2.1 Global Gastrointestinal Drugs Forecast by Regions (2018-2023)
11.2.2 Global Gastrointestinal Drugs Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Gastrointestinal Drugs Forecast by Type
11.8 Global Gastrointestinal Drugs Forecast by Application

12 Key Players Analysis
12.1 AstraZeneca
12.1.1 Company Details
12.1.2 Gastrointestinal Drugs Product Offered
12.1.3 AstraZeneca Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 AstraZeneca News
12.2 Sanofi
12.2.1 Company Details
12.2.2 Gastrointestinal Drugs Product Offered
12.2.3 Sanofi Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Sanofi News
12.3 Bayer
12.3.1 Company Details
12.3.2 Gastrointestinal Drugs Product Offered
12.3.3 Bayer Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Bayer News
12.4 Pfizer
12.4.1 Company Details
12.4.2 Gastrointestinal Drugs Product Offered
12.4.3 Pfizer Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Pfizer News
12.5 GlaxoSmithKline
12.5.1 Company Details
12.5.2 Gastrointestinal Drugs Product Offered
12.5.3 GlaxoSmithKline Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 GlaxoSmithKline News
12.6 Teva
12.6.1 Company Details
12.6.2 Gastrointestinal Drugs Product Offered
12.6.3 Teva Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Teva News
12.7 Zeria(Tillotts)
12.7.1 Company Details
12.7.2 Gastrointestinal Drugs Product Offered
12.7.3 Zeria(Tillotts) Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Zeria(Tillotts) News
12.8 Perrigo
12.8.1 Company Details
12.8.2 Gastrointestinal Drugs Product Offered
12.8.3 Perrigo Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Perrigo News
12.9 Boehringer Ingelheim
12.9.1 Company Details
12.9.2 Gastrointestinal Drugs Product Offered
12.9.3 Boehringer Ingelheim Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Boehringer Ingelheim News
12.10 Purdue Pharma
12.10.1 Company Details
12.10.2 Gastrointestinal Drugs Product Offered
12.10.3 Purdue Pharma Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Purdue Pharma News
12.11 C.B. Fleet
12.12 Abbott
12.13 Jiangzhong
12.14 Xian-Janssen

13 Research Findings and Conclusion


captcha
Enter the code in the box:


captcha
Enter the code in the box:

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may not print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.


captcha
Enter the code in the box:



Summary:
Get latest Market Research Reports on Gastrointestinal Drugs . Industry analysis & Market Report on Gastrointestinal Drugs is a syndicated market report, published as 2018-2023 Global Gastrointestinal Drugs Consumption Market Report. It is complete Research Study and Industry Analysis of Gastrointestinal Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$4,660.00
$6,990.00
$9,320.00
3,129.19
4,693.79
6,258.38
4,288.13
6,432.20
8,576.26
564,512.40
846,768.60
1,129,024.80
309,020.44
463,530.67
618,040.89
Add To Cart Credit card Logo

Related Reports


Reason to Buy